Prévisions du marché de la marijuana médicale en Amérique du Nord jusqu’en 2028 – Impact du COVID-19 et analyse régionale – par type de produit (forme séchée et forme d’extrait), application (gestion de la douleur, maladie de la Tourette, maladie d’Alzheimer, migraines, dépression et anxiété, Sclérose en plaques, cancer et autres) et canal de distribution (pharmacie de détail, commerce électronique et autres)

Le marché nord-américain de la marijuana médicale devrait passer de 7 170,17 millions de dollars américains en 2022 à 20 760,41 millions de dollars américains d\'ici 2028. On estime qu\'il enregistrera un TCAC de 19,4 % de 2022 à 2028. ;

L\'augmentation des approbations de produits à base de marijuana médicale alimente la croissance du marché de la marijuana médicale en Amérique du Nord

< p>Le potentiel médicinal de la marijuana a incité divers chercheurs et entreprises à utiliser la marijuana à des fins médicales. Par exemple, le tétrahydrocannabinol (THC) est principalement utilisé pour la production de médicaments. La Food and Drug Administration (FDA) des États-Unis a approuvé des médicaments à base de THC tels que le Cesamet, qui contient de la naboline comme ingrédient actif, un produit dérivé de synthèse qui a une structure similaire au THC. Cesamet est prescrit pour le traitement des nausées chez les patients recevant une chimiothérapie. Cesamet est généralement prescrit lorsque d\'autres médicaments ne peuvent pas contrôler les nausées et les vomissements. La FDA a également approuvé Marinol et Syndros pour des usages thérapeutiques aux États-Unis. Marinol et Syndros contiennent l\'ingrédient actif dronabinol, un 9-THC synthétique considéré comme le composant psychoactif du cannabis. Les médicaments Marinol et Syndros sont prescrits pour stimuler l\'appétit chez les patients atteints du syndrome d\'émaciation, développé comme l\'une des indications du SIDA. De même, divers produits à base de marijuana ont été approuvés ou sont en cours d’essais cliniques. Par exemple, le nabiximols (Sativex) est un médicament approuvé et commercialisé au Canada. Le nabiximols est un extrait de cannabis utilisé pour traiter la spasticité et les douleurs neuropathiques liées à la sclérose en plaques. Il est formulé avec une combinaison de THC et d’autres cannabidiol (CBD). En février 2020, CanaQuest Medical Corp, une entreprise canadienne, a demandé l\'approbation de la production et de la commercialisation du Mentabinol à Santé Canada. Le Mentabinol est un produit à base de THC et sa demande d\'approbation a été déposée en vertu de la Loi sur le cannabis. L\'augmentation du nombre d\'approbations par la FDA des produits à base de marijuana mentionnés ci-dessus stimule le marché de la marijuana médicale.

Aperçu du marché de la marijuana médicale en Amérique du Nord

Le marché nord-américain de la marijuana médicale est segmenté entre les États-Unis, le Canada et le Mexique. On estime que le marché de la marijuana médicale détient la plus grande part aux États-Unis. La croissance du marché de la marijuana médicale peut être attribuée à l’augmentation de la recherche et des collaborations pour explorer des applications thérapeutiques innovantes, à la sensibilisation croissante à la marijuana médicale et à la présence d’acteurs clés dans la région. En outre, le vieillissement croissant de la population dans la région favorisera également la croissance du marché.

Revenus et prévisions du marché de la marijuana médicale en Amérique du Nord jusqu\'en 2028 (États-Unis Millions de dollars)

Marché nord-américain de la marijuana médicale Segmentation

Le marché nord-américain de la marijuana médicale est segmenté en type de produit, application, canal de distribution et pays.

En fonction du type de produit, le marché nord-américain de la marijuana médicale est segmenté en forme séchée et sous forme d\'extrait. Le segment des extraits détenait une part plus importante du marché nord-américain de la marijuana médicale en 2022.

Sur la base des applications, le marché nord-américain de la marijuana médicale est segmenté en gestion de la douleur, Tourette, maladie d\'Alzheimer, migraines, dépression et anxiété, sclérose en plaques, cancer et autres. Le segment de la gestion de la douleur détenait la plus grande part du marché de la marijuana médicale en Amérique du Nord en 2022.

Sur la base du canal de distribution, le marché de la marijuana médicale en Amérique du Nord est segmenté en pharmacie de détail, e -commerce, et autres. Le segment des pharmacies de détail détenait la plus grande part du marché de la marijuana médicale en Amérique du Nord en 2022.

En fonction des pays, le marché de la marijuana médicale en Amérique du Nord est segmenté entre les États-Unis, le Canada, et le Mexique. Les États-Unis ont dominé le marché nord-américain de la marijuana médicale en 2022.

Aphria, Inc. ; Société médicale CanaQuest ; Société de croissance de la canopée ; Thérapeutique Santé Émeraude Inc. ; Produits pharmaceutiques GW ; MARICANN INC.; Organigramme Holdings Inc. ; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc. ; et VIVO Cannabis Inc sont les principales sociétés opérant sur le marché nord-américain de la marijuana médicale.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Medical Marijuana Market – by Product

1.3.2 North America Medical Marijuana Market – by Application

1.3.3 North America Medical Marijuana Market – by Distribution Channel

1.3.4 North America Medical Marijuana Market – by Country

2. North America Medical Marijuana Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Medical Marijuana Market – Market Landscape

4.1 Overview

4.2 North America – PEST Analysis

4.3 Expert Opinion

5. North America Medical Marijuana Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Approvals of Medical Marijuana Products

5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America

5.2 Market Restraints

5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana

5.3 Market Opportunities

5.3.1 Increase in Job Opportunities in Marijuana Industry

5.4 Future Trends

5.4.1 Widespread Distribution of Medical Marijuana

5.5 Impact Analysis

6. Medical Marijuana Market – North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

7.3 Dried Form

7.3.1 Overview

7.3.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Extract Form

7.4.1 Overview

7.4.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis – by Application

8.1 Overview

8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

8.3 Pain Management

8.3.1 Overview

8.3.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Tourette’s

8.4.1 Overview

8.4.2 Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Alzheimer’s Disease

8.5.1 Overview

8.5.2 Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Migraines

8.6.1 Overview

8.6.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Depression and Anxiety

8.7.1 Overview

8.7.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Multiple Sclerosis

8.8.1 Overview

8.8.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Cancer

8.9.1 Overview

8.9.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market – by Distribution Channel

9.1 Overview

9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

9.3 Retail Pharmacy

9.3.1 Overview

9.3.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.4 E-Commerce

9.4.1 Overview

9.4.2 E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2 US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2 Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2 Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Medical Marijuana Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Panaxia Pharmaceutical Industries Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Phoena Holdings Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Emerald Health Therapeutics Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 MARICANN INC.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Aphria, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Canopy Growth Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CanaQuest Medical Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 GW Pharmaceuticals

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Organigram Holdings Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for North America Medical Marijuana Market

LIST OF TABLES

Table 1. US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 3. US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 6. Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 9. Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10. Organic Developments in the Medical Marijuana Market

Table 11. Inorganic Developments in the Medical Marijuana Market

Table 12. Glossary of Terms for North America Medical Marijuana Market

LIST OF FIGURES

Figure 1. North America Medical Marijuana Market Segmentation

Figure 2. North America Medical Marijuana Market, By Country

Figure 3. North America Medical Marijuana Market Overview

Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market

Figure 5. US to Show Remarkable Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

Figure 9. Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

Figure 12. Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

Figure 21. Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

Figure 26. US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000